Open AccessReal-world data on the efficacy and safety of pazopanib in IMDC favorable- and intermediate-risk metastatic renal cell carcinoma: a multicenter retrospective cohort study of Chinese patients
Author(s) -
Aihetaimujiang Anwaier,
Jianhui Chen,
Hongfeng Zhou,
Xinxin Zhao,
Song Zheng,
Xiaofan Li,
Yuanyuan Qu,
Guohai Shi,
Hailiang Zhang,
Jin Wu,
Dingwei Ye
Publication year - 2022
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau-22-312
Subject(s) - pazopanib , medicine , renal cell carcinoma , oncology , retrospective cohort study , adverse effect , cohort , surgery , sunitinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom